64 related articles for article (PubMed ID: 29489051)
1. Folliculotropism in Actinic Keratoses in Patients not Responding to Treatments: A Pilot Study.
Dika E; Dika E; Lambertini M; Dika E; Lambertini M; Veronesi G; Misciali C; Milani M; Bergant-Suhodolcan A; Hrvatin Stancic B; Baraldi C
Acta Dermatovenerol Croat; 2023 Nov; 31(2):98-100. PubMed ID: 38006370
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA-seq reveals actinic keratosis-specific keratinocyte subgroups and their crosstalk with secretory-papillary fibroblasts.
Li J; Xia Y; Kong S; Yang K; Chen H; Zhang Y; Liu D; Chen L; Sun X
J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2273-2283. PubMed ID: 37357444
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and therapy of actinic keratosis.
Thamm JR; Welzel J; Schuh S
J Dtsch Dermatol Ges; 2024 May; 22(5):675-690. PubMed ID: 38456369
[TBL] [Abstract][Full Text] [Related]
4. Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma.
Inan Yuksel E; Cicek D; Demir B; Kocaman N; Calik I; Kuloglu T
Biotech Histochem; 2024 Feb; 99(2):61-68. PubMed ID: 38192243
[TBL] [Abstract][Full Text] [Related]
5. Needs and challenges among general practitioners in the management of actinic keratosis: a qualitative study.
Verhoeven C; Claessens Z; Lubeek SFK; Schers HJ
BMC Prim Care; 2023 Dec; 24(1):260. PubMed ID: 38042808
[TBL] [Abstract][Full Text] [Related]
6. Follicular (Infundibular-Tricholemmal) Squamous Cell Carcinoma: A New WHO Entity. Clinicopathological Features in 103 Cases, Including Follow-Up and Implications for Patient Management.
Carr RA; Wiggins J; Slater DN
Am J Dermatopathol; 2024 Apr; ():. PubMed ID: 38648027
[TBL] [Abstract][Full Text] [Related]
7. Digitally Enhanced Methods for the Diagnosis and Monitoring of Treatment Responses in Actinic Keratoses: A New Avenue in Personalized Skin Care.
Soare C; Cozma EC; Celarel AM; Rosca AM; Lupu M; Voiculescu VM
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339236
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53, p63, p16, Ki67, Cyclin D, Bcl-2, and CD31 Markers in Actinic Keratosis, In Situ Squamous Cell Carcinoma and Normal Sun-Exposed Skin of Elderly Patients.
Balcere A; Sperga M; Čēma I; Lauskis G; Zolovs M; Rone Kupfere M; Krūmiņa A
J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068343
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma.
Hedberg ML; Berry CT; Moshiri AS; Xiang Y; Yeh CJ; Attilasoy C; Capell BC; Seykora JT
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408839
[TBL] [Abstract][Full Text] [Related]
10. A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.
Del Regno L; Catapano S; Di Stefani A; Cappilli S; Peris K
Am J Clin Dermatol; 2022 May; 23(3):339-352. PubMed ID: 35182332
[TBL] [Abstract][Full Text] [Related]
11. Dual-Wavelength Fluorescence Monitoring of Photodynamic Therapy: From Analytical Models to Clinical Studies.
Kirillin M; Khilov A; Kurakina D; Orlova A; Perekatova V; Shishkova V; Malygina A; Mironycheva A; Shlivko I; Gamayunov S; Turchin I; Sergeeva E
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830963
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin.
Fernández-Figueras MT; Carrato C; Sáenz X; Puig L; Musulen E; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2015 May; 29(5):991-7. PubMed ID: 25428612
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition contributes to invasion in squamous cell carcinomas originated from actinic keratosis through the differentiated pathway, whereas proliferation plays a more significant role in the classical pathway.
Saenz-Sardà X; Carrato C; Pérez-Roca L; Puig L; Ferrándiz C; Ariza A; Fernández-Figueras MT
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):581-586. PubMed ID: 28796927
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.
Schmitz L; Gambichler T; Kost C; Gupta G; Stücker M; Stockfleth E; Dirschka T
Br J Dermatol; 2019 Apr; 180(4):916-921. PubMed ID: 29526028
[TBL] [Abstract][Full Text] [Related]
15. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited.
Fernandez Figueras MT
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():5-7. PubMed ID: 28263020
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for actinic keratosis.
Ulrich M; Drecoll U; Stockfleth E
Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
[TBL] [Abstract][Full Text] [Related]
17. The depth of follicular extension in actinic keratosis correlates with the depth of invasion in squamous cell carcinoma: implication for clinical treatment.
Fernández-Figueras MT; Saenz-Sardà X; Vargas P; Thompson CT; Carrato C; Puig L; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1657-1661. PubMed ID: 29489051
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
